Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-22-026415
Filing Date
2022-10-14
Accepted
2022-10-14 16:22:33
Documents
4
Period of Report
2022-10-14

Document Format Files

Seq Description Document Type Size
1 PRE 14A specialmeetingproxydecembe.htm PRE 14A 126218
2 image1a.jpg GRAPHIC 302079
3 image_0a.jpg GRAPHIC 7178
4 imagea.jpg GRAPHIC 670943
  Complete submission text file 0001628280-22-026415.txt   1477775
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

EIN.: 201450200 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36783 | Film No.: 221311580
SIC: 2834 Pharmaceutical Preparations